| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | — | — | — | — | — | — | — |
| EPS (Basic) | $2.41 | $2.01 | $1.94 | $1.57 | $1.94 | $1.30 | $1.73 | $1.73 |
| EPS (Diluted) | $2.41 | $2.01 | $1.94 | $1.57 | $1.94 | $1.30 | $1.73 | $1.73 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.9B | $22.5B | $22.7B | $22.9B | $18.1B | $16.4B | $15.0B | $15.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.7B | $0.9B | $1.0B | $0.7B | $3.7B | $1.3B | $0.5B | $0.7B |
| Total Liabilities | $18.6B | $18.5B | $18.9B | $19.4B | $15.3B | $13.8B | $12.5B | $13.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $4.3B | $4.0B | $3.8B | $3.5B | $2.8B | $2.6B | $2.5B | $2.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B | $0.2B | $0.3B |
| Investing Cash Flow | $-0.5B | $0.0B | $0.6B | $-1.0B | $0.6B | $-0.7B | $0.2B | $-0.8B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.2B | $-0.6B | $-0.7B | $-2.3B | $1.4B | $1.1B | $-0.6B | $0.5B |